196 related articles for article (PubMed ID: 34108600)
21. Effect of PI3K/Akt Signaling Pathway on the Process of Prostate Cancer Metastasis to Bone.
Zhu W; Hu X; Xu J; Cheng Y; Shao Y; Peng Y
Cell Biochem Biophys; 2015 May; 72(1):171-7. PubMed ID: 27040945
[TBL] [Abstract][Full Text] [Related]
22. Notch-4 silencing inhibits prostate cancer growth and EMT via the NF-κB pathway.
Zhang J; Kuang Y; Wang Y; Xu Q; Ren Q
Apoptosis; 2017 Jun; 22(6):877-884. PubMed ID: 28374086
[TBL] [Abstract][Full Text] [Related]
23. The Effect of a Histone Deacetylase Inhibitor (AR-42) on Canine Prostate Cancer Growth and Metastasis.
Elshafae SM; Kohart NA; Altstadt LA; Dirksen WP; Rosol TJ
Prostate; 2017 May; 77(7):776-793. PubMed ID: 28181686
[TBL] [Abstract][Full Text] [Related]
24. Down-regulation of E-cadherin enhances prostate cancer chemoresistance via Notch signaling.
Wang W; Wang L; Mizokami A; Shi J; Zou C; Dai J; Keller ET; Lu Y; Zhang J
Chin J Cancer; 2017 Mar; 36(1):35. PubMed ID: 28356132
[TBL] [Abstract][Full Text] [Related]
25. Suppression of Akt1-β-catenin pathway in advanced prostate cancer promotes TGFβ1-mediated epithelial to mesenchymal transition and metastasis.
Gao F; Alwhaibi A; Sabbineni H; Verma A; Eldahshan W; Somanath PR
Cancer Lett; 2017 Aug; 402():177-189. PubMed ID: 28602980
[TBL] [Abstract][Full Text] [Related]
26. Antitumor and antimetastatic activities of docetaxel are enhanced by genistein through regulation of osteoprotegerin/receptor activator of nuclear factor-kappaB (RANK)/RANK ligand/MMP-9 signaling in prostate cancer.
Li Y; Kucuk O; Hussain M; Abrams J; Cher ML; Sarkar FH
Cancer Res; 2006 May; 66(9):4816-25. PubMed ID: 16651437
[TBL] [Abstract][Full Text] [Related]
27. Silibinin inhibits fibronectin induced motility, invasiveness and survival in human prostate carcinoma PC3 cells via targeting integrin signaling.
Deep G; Kumar R; Jain AK; Agarwal C; Agarwal R
Mutat Res; 2014 Oct; 768():35-46. PubMed ID: 25285031
[TBL] [Abstract][Full Text] [Related]
28. SNAI1 is critical for the aggressiveness of prostate cancer cells with low E-cadherin.
Deep G; Jain AK; Ramteke A; Ting H; Vijendra KC; Gangar SC; Agarwal C; Agarwal R
Mol Cancer; 2014 Feb; 13():37. PubMed ID: 24565133
[TBL] [Abstract][Full Text] [Related]
29. The inhibition of RANKL/RANK signaling by osteoprotegerin suppresses bone invasion by oral squamous cell carcinoma cells.
Shin M; Matsuo K; Tada T; Fukushima H; Furuta H; Ozeki S; Kadowaki T; Yamamoto K; Okamoto M; Jimi E
Carcinogenesis; 2011 Nov; 32(11):1634-40. PubMed ID: 21890459
[TBL] [Abstract][Full Text] [Related]
30. MicroRNA-466 inhibits tumor growth and bone metastasis in prostate cancer by direct regulation of osteogenic transcription factor RUNX2.
Colden M; Dar AA; Saini S; Dahiya PV; Shahryari V; Yamamura S; Tanaka Y; Stein G; Dahiya R; Majid S
Cell Death Dis; 2017 Jan; 8(1):e2572. PubMed ID: 28125091
[TBL] [Abstract][Full Text] [Related]
31. Bone Metastasis of Prostate Cancer Can Be Therapeutically Targeted at the TBX2-WNT Signaling Axis.
Nandana S; Tripathi M; Duan P; Chu CY; Mishra R; Liu C; Jin R; Yamashita H; Zayzafoon M; Bhowmick NA; Zhau HE; Matusik RJ; Chung LW
Cancer Res; 2017 Mar; 77(6):1331-1344. PubMed ID: 28108510
[TBL] [Abstract][Full Text] [Related]
32. Epithelial to mesenchymal transition (EMT) in human prostate cancer: lessons learned from ARCaP model.
Zhau HE; Odero-Marah V; Lue HW; Nomura T; Wang R; Chu G; Liu ZR; Zhou BP; Huang WC; Chung LW
Clin Exp Metastasis; 2008; 25(6):601-10. PubMed ID: 18535913
[TBL] [Abstract][Full Text] [Related]
33. RANK ligand inhibition plus docetaxel improves survival and reduces tumor burden in a murine model of prostate cancer bone metastasis.
Miller RE; Roudier M; Jones J; Armstrong A; Canon J; Dougall WC
Mol Cancer Ther; 2008 Jul; 7(7):2160-9. PubMed ID: 18606716
[TBL] [Abstract][Full Text] [Related]
34. Wogonoside Inhibits Prostate Cancer Cell Growth and Metastasis via Regulating Wnt/β-Catenin Pathway and Epithelial-Mesenchymal Transition.
Wei C; Jing J; Zhang Y; Fang L
Pharmacology; 2019; 104(5-6):312-319. PubMed ID: 31480051
[TBL] [Abstract][Full Text] [Related]
35. Loss of exosomal miR-146a-5p from cancer-associated fibroblasts after androgen deprivation therapy contributes to prostate cancer metastasis.
Zhang Y; Zhao J; Ding M; Su Y; Cui D; Jiang C; Zhao S; Jia G; Wang X; Ruan Y; Jing Y; Xia S; Han B
J Exp Clin Cancer Res; 2020 Dec; 39(1):282. PubMed ID: 33317606
[TBL] [Abstract][Full Text] [Related]
36. DNMT1 Regulates Epithelial-Mesenchymal Transition and Cancer Stem Cells, Which Promotes Prostate Cancer Metastasis.
Lee E; Wang J; Yumoto K; Jung Y; Cackowski FC; Decker AM; Li Y; Franceschi RT; Pienta KJ; Taichman RS
Neoplasia; 2016 Sep; 18(9):553-66. PubMed ID: 27659015
[TBL] [Abstract][Full Text] [Related]
37. Targeting the SPOCK1-snail/slug axis-mediated epithelial-to-mesenchymal transition by apigenin contributes to repression of prostate cancer metastasis.
Chien MH; Lin YW; Wen YC; Yang YC; Hsiao M; Chang JL; Huang HC; Lee WJ
J Exp Clin Cancer Res; 2019 Jun; 38(1):246. PubMed ID: 31182131
[TBL] [Abstract][Full Text] [Related]
38. Induction of retinol-binding protein 4 and placenta-specific 8 expression in human prostate cancer cells remaining in bone following osteolytic tumor growth inhibition by osteoprotegerin.
Uehara H; Takahashi T; Izumi K
Int J Oncol; 2013 Aug; 43(2):365-74. PubMed ID: 23708710
[TBL] [Abstract][Full Text] [Related]
39. Activation of BDNF/TrkB pathway promotes prostate cancer progression via induction of epithelial-mesenchymal transition and anoikis resistance.
Li T; Yu Y; Song Y; Li X; Lan D; Zhang P; Xiao Y; Xing Y
FASEB J; 2020 Jul; 34(7):9087-9101. PubMed ID: 32390303
[TBL] [Abstract][Full Text] [Related]
40. Downregulation of miR-141-3p promotes bone metastasis via activating NF-κB signaling in prostate cancer.
Huang S; Wa Q; Pan J; Peng X; Ren D; Huang Y; Chen X; Tang Y
J Exp Clin Cancer Res; 2017 Dec; 36(1):173. PubMed ID: 29202848
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
